isogenic cell lines
Horizon, Thermo Fisher Sign Marketing Deal
Thermo Fisher will market Horizon's X-MAN human haploid and diploid isogenic cell line collection.
Horizon's Cell Lines to Aid Sanger, Mass General in Guiding Oncologics Administration with PGx
Premium
The UK-based firm will provide Sanger with more than 200 genetically defined cell lines with cancer-causing mutations, which will guide researchers working on the Genomics of Drug Sensitivity in Cancer project.
Genentech to Use Horizon's X-MAN Line
Expanding their relationship, the cancer drug developer will use the mutant-and-normal cell line library.
Horizon Discovery to Collaborate with Novartis
Horizon will develop X-MAN cancer models for the drug developer's therapeutic research programs.
Horizon, Univ. of Liverpool to Collaborate on Cancer Biomarkers
The partners will use Horizon's cell lines to identify unique protein biomarker signatures.
Oct 13, 2009
Horizon Discovery Inks Service Agreement with GSK
Aug 25, 2009
Horizon Discovery, Silicos Ink Screening Pact
Aug 11, 2009
Newcastle University to Use Horizon's X-MAN Models
Aug 6, 2009
Horizon Inks License for Cell Line IP
Aug 4, 2009
Janssen to Use Horizon Cell Lines in Research
Jul 16, 2009